Global Projects

I graduated in Genetics at the Autonomous University of Barcelona (UAB) in 2014, then I completed a master’s degree in Biological Anthropology, Human Diversity and Biomedical Applications at the University of Barcelona together with the Autonomous University of Barcelona in 2015. At this time, I performed my master’s thesis focused on the genetic study of Lewy body diseases, supervised by Dr. Katrin Beyer and Dr. Cristina Santos at the Hospital Germans Trias i Pujol. Following with neuroscience research, I pursued my PhD (2020) in the mitochondrial neuropathology lab led by Dr. Albert Quintana and Dr. Elisenda Sanz. I was keen on deciphering the neuronal type specific contribution at transcriptomic (nuclear and mitochondrial) level in Leigh syndrome mitochondrial disorder. Supporting this research, I did a short stay in Dr. Rita Horvath’s lab in Cambridge University (UK).  Additionally, I collaborated with industry stakeholders in pre-clinical pharmacological studies for mitochondrial pathologies, coordinated a master’s thesis and collaborated in university teaching at the UAB. Then, I decided to direct my career path towards a translational research and clinical support. In 2021 I joined Hereditary Cancer Group at the IDIBELL as Project Manager while coursing a clinical genetics postgraduate course.

Guillem obtained his B.Sc. in Molecular Biology by the University of Barcelona (UB) in 2013, performing research internships in both the Developmental Genetics and Biology group and the Unit of Botany of the University of Barcelona (UB) as well as the Chromatin Dynamics group at the University of Copenhagen (KU). He performed a research internship in the group of Dr. Kristian Helin at the Biotech Research & Innovation Center in Copenhagen, Denmark (2013-2014), and continued his studies obtaining an M.Sc. in Human Biology by the University of Copenhagen (KU) (2016). He performed his master thesis at the laboratory of Dr. Kim Jensen at the Biotech Research & Innovation Center (currently reNEW) in Copenhagen, Denmark (2016). He pursued his Ph.D. in Biomedicine at the Hematopoietic Stem Cells, Transdifferentiation and Reprogramming group led by Dr. Thomas Graf at the Centre for Genomic Regulation (CRG) in Barcelona. He defended his Ph.D. thesis in 2022, focusing on the role of post-translational modifications of transcription factors in cell fate decisions. He joined the Hereditary Cancer group at IDIBELL as a Project Manager to aid in the steering of global translational and clinical projects.

I am a postdoctoral researcher graduated in Genetics from the Universitat Autònoma de Barcelona (UAB) in 2015. I continued my university education with the Postgraduate course in Medical Genetics by the Universitat de València (2016-2017) and the Master’s Degree in Cytogenetics and Reproductive Biology by UAB (2017-2018). I did my Master Thesis in the Genetics of Male Fertility Group, characterizing genetic risk in carriers of chromosome heteromorphisms. After that, I started my Phd (2018-2021) at the same group, under the joint supervision of Dra. Francesca Vidal and Dr. Joan Blanco. There, I studied 22q11.2 deletion syndrome as a model study for the integral analysis of genetic factors that predispose genomic disorders. At this time, I entered at the Next Generation Sequencing (NGS) analysis world. Meanwhile, I collaborated in the study of clonal heterogeneity and evaluation in relapse high-hyperdiploid B-cell acute lymphoblastic leukaemia, with Dr. Oscar Molina and Dr. Pablo Menéndez from Josep Carreras Leukaemia Research Institute. During these years, I published two books and several divulgation articles to bring genetics to the general population. In 2021 I joined to Hereditary Cancer Group at IDIBELL as a NGS data analyst.